Skip to main content
DVA
NYSE Life Sciences

Washington State Sues DaVita, Fresenius Over Nephrologist Noncompetes

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$180.235
Mkt Cap
$11.337B
52W Low
$101
52W High
$247.49
52W Position info
78% above low
Off High info
27% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

DVA sits 78% above its 52-week low of $101.

Summary

Washington's attorney general filed an antitrust suit in Thurston County accusing DaVita and Fresenius of using noncompete agreements for medical directors to block competing dialysis centers. The state wants all current and former medical director noncompetes voided and civil fines of up to $7,500 per violation. DaVita operates 51 dialysis centers in Washington and Fresenius 29; DaVita called the allegations a 'fundamentally distorted picture' and said it will vigorously defend the arrangements. This is a state-level escalation of the FTC's April 2024 investigation into the same noncompete practice, which both companies have said they are cooperating with. Financial exposure from fines is modest for a company of DaVita's size, but a ruling voiding medical director noncompetes could open its dialysis markets to new entrants. Berkshire Hathaway owns about 45% of DaVita.

At the time of this announcement, DVA was trading at $180.24 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $101.00 to $247.49. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

DVA - Latest Insights

DVA
Oct 29, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $180.00
Real-time Price: $179.28 info
Change: -$0.720 (-0.40%) info
Market Cap: $11.277B info
DVA
Oct 29, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $184.00
Real-time Price: $179.28 info
Change: -$4.72 (-3%) info
Market Cap: $11.277B info
DVA
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $193.31
Real-time Price: $179.28 info
Change: -$14.03 (-7%) info
Market Cap: $11.277B info
DVA
Sep 04, 2026, 10:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $182.70
Real-time Price: $179.28 info
Change: -$3.42 (-2%) info
Market Cap: $11.277B info
DVA
Aug 25, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $176.50
Real-time Price: $179.28 info
Change: +$2.78 (+2%) info
Market Cap: $11.277B info